First-trimester fetal diagnosis for haemoglobinopathies: report on 200 cases.
First-trimester prenatal diagnosis by DNA analysis was found to be possible in 224 (80%) of 281 families at risk of having a child with beta-thalassaemia major. 200 prenatal diagnoses, mainly for beta-thalassaemia or sickle-cell anaemia, were made by means of chorionic villus sampling and fetal DNA analysis. The overall fetal loss rate was 6.7%, the majority being in the first half of the programme. There was one misdiagnosis. Prenatal diagnosis was also carried out successfully for both pairs of twins in two pregnancies. Comparison of these results with 53 prenatal diagnoses made with DNA prepared from amniotic fluid suggests that the first-trimester procedure is more reliable. If further experience confirms that chorionic villus sampling has an acceptably low risk for both mother and fetus it will largely replace other methods for prenatal diagnosis of the haemoglobin disorders and other single-gene conditions.
D000653:Amniotic Fluid / Q000032:analysis; D000755:Anemia, Sickle Cell / Q000175:diagnosis; D002824:Chorionic Villi / Q000032:analysis; D004247:DNA / Q000032:analysis; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis*; D005796:Genes; D006453:Hemoglobinopathies / Q000175:diagnosis*; D006801:Humans; D011110:Polymorphism, Genetic; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011296:Prenatal Diagnosis; D013789:Thalassemia / Q000175:diagnosis / Q000235:genetics
D004247:DNA